94430 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms
LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANIC COMPOUND
#2CRYSTAL FORM OF ERGOTHIONEINE
#3POLYMORPHIC FORM OF NEPICASTAT ACID ADDITION SALT, PREPARATION METHOD THEREFOR AND USE THEREOF
#4LOW-ODOR, HIGH-STABILITY ERGOTHIONEINE CRYSTAL
#5SALTS OF AN ANTIOXIDANT AND CRYSTALLINE FORMS THEREOF
#6SELECTIVE HDAC6 INHIBITOR
#7New Coolants, and Preparations Containing Same
#8Process for Chemical Synthesis of Ergothioneine and Methods of Use
#9COMPOUNDS AND USES THEREOF IN THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS ASSOCIATE WITH OR AGGRAVATED BY IMPAIRED MITOPHAGY OR OXIDATIVE STRESS
#10HETEROARYL-THIO-SUBSTITUTED PYRONES
#11PROTEIN AND LIPID THERAPEUTIC TARGETS
#12MUTANT SELECTIVE EGFR INHIBITORS AND METHODS OF USE THEREOF
#13QUORUM SENSING INHIBITORS AND METHODS OF USE
#14Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
#15Cannabinoid derivatives
#16ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#17EGFR dimer disruptors and use of the same
#18PLANT GROWTH REGULATOR AND METHOD FOR PROMOTING PLANT GROWTH
#19Heteroaryl-thio-substituted pyrones
#20Non-aqueous electrolyte solution additive, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same
#21Arylazole compound and pest control agent
#22TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#23Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
#24Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers
#25Compounds
#26SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#27BUMETANIDE DERIVATIVES FOR THE THERAPY OF HYPERHIDROSIS
#28Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
#29EGFR dimer disruptors and use of the same
#30FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF
#31Sulfonamide carboxamide compounds
#32SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#33Androgen receptor modulators and methods for their use
#34Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#35ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#36TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#37Imidazole and thiazole compositions for modifying biological signaling
#38NOVEL 5-ACYLSULFANYL-HISTIDINE COMPOUNDS AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THEIR DISULFIDES
#39SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF
#40Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents
#415-substituted imidazole derivatives
#42Composition comprising a fluorine-containing surfactant
#43Imidazole and thiazole compositions for modifying biological signaling
#44Arylazole compound and pest control agent
#45TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#465-SULFANYLHISTIDINES AND THEIR DISULFIDES AND METHOD OF PREPARATION THEREOF
#47Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#48Dithiolene metal complex colorless IR absorbers
#495-substituted imidazole derivatives
#50Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#51Herbicidal compounds
#52TETRACYCLINE COMPOUNDS
#53Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
#54Process for synthesizing ergothioneine and related compounds
#55Dithiolene metal complex colorless IR absorbers
#56Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#57TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#58Imidazole and thiazole compositions for modifying biological signaling
#59Prevention and treatment of non-alcoholic fatty liver disease
#605-acylsulfanyl-histidine compounds as precursors of the corresponding 5-sulfanylhistidines and their disulfides
#61DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#62Vinylogous thioester compounds and methods of use
#63N, N, N-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
#64N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#65Dithiolene metal complex colorless IR absorbers
#66N-substituted benzamides and methods of use thereof
#67Fluorination of organic compounds
#68ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
#69N, N, N-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
#70Prevention and treatment of non-alcoholic fatty liver disease
#71Cytochrome P450 inhibitors and their method of use
#72Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
#73Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase
#74Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#75Glucagon receptor modulators
#76Tetralin and indane derivatives and uses thereof
#77Acylpiperazines as inhibitors of transglutaminase and their use in medicine
#78Potassium channel blockers
#79Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#80Modulators for Sirt5 and assays for screening same
#81Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein
#82ANTI-INFECTIVE COMPOUNDS
#83Difluoromethylation of unsaturated compounds
#84DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#85Glucagon receptor modulators
#86Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#87Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
#88Substituted hydroxamic acids and uses thereof
#89Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#90Anions and derived salts with high dissociation in non-protogenic solvents
#91Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
#92SUBSTITUTED DIARYL DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS
#93Ketone compounds and compositions for cholesterol management and related uses
#94Inhibition of cell proliferation
#95Potassium channel blockers
#96Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
#97Imidazole compounds that modulate HSP90 activity
#98Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#99Specific diarylhydantoin and diarylthiohydantoin compounds
#100N-substituted benzamides and methods of use thereof
#101N-substituted benzamides and methods of use thereof
#102TGR5 agonists
#103Glucagon receptor modulators
#104HETEROARYLTHIO DERIVATIVES AND ANALOGUES
#105Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives
#106Use of aryl or heteroaryl substituted dithiolene metal complexes as IR absorbers
#107Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
#108Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
#109Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#110Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
#111Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#112NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
#113Method for the synthesis of 2-thiohistidine and the like
#114Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#115Benzyl amines, a process for their production and their use as anti-inflammatory agents
#116Dual-acting antihypertensive agents
#117Process for the preparation of a compound useful as an inhibitor of TAFIa
#118Tetracycline compounds
#119Glucagon receptor modulators
#120UNSUBSTITUTED AND SUBSTITUTED 4-BENZYL-1,3-DIHYDRO-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC OR SELECTIVE ALPHA2 ADRENERGIC AGONISTS AND METHODS FOR USING THE SAME
#121UREA SUBSTITUTED SULPHONAMIDE DERIVATIVES
#122TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS
#123Method of synthesizing ergothioneine and analogs
#1244-(1-(3-(HYDROXYMETHYL)-2-METHYLPHENYL)ETHYL)-1H-IMIDAZOLE-2(3H)-THIONE
#125Ketone compounds and compositions for cholesterol management and related uses
#126Compounds, Compositions and Methods for Modulating Uric Acid Levels
#127Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#128Tetralin and indane derivatives and uses thereof
#129Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
#130Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity
#131Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
#132Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#133Specific diarylhydantoin and diarylthiohydantoin compounds
#134Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#13511-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
#136Iminopropene compound and use thereof
#137Glycine transporter-1 inhibitors, methods of making them, and uses thereof
#138Benzyl, amines, a process for their production and their use as anti-inflammatory agents
#139Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
#140Imidazole derivatives useful as inhibitors of FAAH
#141Dual-acting antihypertensive agents
#142Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation
#143Systems for carbon dioxide and sulfur dioxide removal
#144IONIC LIQUID SYSTEMS FOR CARBON DIOXIDE AND SULFUR DIOXIDE REMOVAL
#145SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#146Anti-infective compounds
#147Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#148Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
#149Compound containing basic group and use thereof
#150Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#151COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE
#152SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#153SUBSTITUTED PHENOXYBENZAMIDES
#154Nonsedating α-2 agonists
#155Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alphaadrenergic agonists and methods for using the same
#15611β-hydroxysteroid dehydrogenase type 1 active compounds
#157Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#158Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#159Sulfonyl-substituted 6-membered ring derivative
#160Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
#161Mitochondria-targeted antioxidant prodrugs and methods of use
#1624-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
#163Ketone compounds and compositions for cholesterol management and related uses
#164Cyclohexyl sulfonamide derivatives
#165Potassium channel blockers
#166Potassium channel blockers
#167Potassium channel blockers
#168Compounds, compositions and methods of using same for modulating uric acid levels
#169Compounds, compositions and methods of using same for modulating uric acid levels
#170BIARYL SULFONAMIDE DERIVATIVES
#171Apoptosis promoters
#172DITHIOLENE METAL COMPLEX COLORLESS IR ABSORBERS
#173Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
#174NON-IMIDAZOLE ARYLOXYALKYLAMINES
#175Dual-acting antihypertensive agents
#176BCRP/ABCG2 inhibitor
#177Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#178MERCAPTOIMIDAZOLES AS CCR2 RECEPTOR ANTAGONISTS
#179Binding inhibitor of sphingosine-1-phosphate
#180Inhibitors of histone deacetylase
#1814-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
#182TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#183Malononitrile compound as pesticides
#184Scalable synthesis of imidazole derivatives
#185Non-nucleoside reverse transcriptase inhibitors
#186Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
#187Process for the synthesis of L-(+)-ergothioneine
#188Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#189Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
#190Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
#191Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
#192Therapeutic Agents
#1934-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
#194NON-IMIDAZOLE ARYLOXYALKYLAMINES
#195Tetralin and indane derivatives and uses thereof
#196New amino-alkyl-amide derivatives as CCR3 receptor ligands
#197NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
#1984-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compounds
#199Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators
#200Nonsedating Alpha-2 Agonists
#201Solventless one-step process for the production of imidazole-2-thiones
#2022-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
#203Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids
#204Inhibitors of histone deacetylase
#205Hemiasterlin Derivatives and Uses Thereof
#206Imidazole-2-thiones
#207Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#208Imidazole-2-thiones
#209ION CHANNEL MODULATORS
#210Asthma and allergic inflammation modulators
#2114-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alphaagonist and methods of using the same
#212Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#213CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS
#214Benzyl amines, a process for their production and their use as anti-inflammatory agents
#215Compound containing basic group and use thereof
#216Iminopropene compound and use thereof
#217BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
#218Ion Channel Modulators
#219Inhibition of cell proliferation
#220Mercaptoimidazoles as Ccr2 Receptor Antagonists
#221Mercaptoimidazoles as Ccr2 Receptor Antagonists
#222Aminoalkylphosphonates and related compounds as Edg receptor agonists
#223N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#224Ion channel modulators
#225Ion channel modulators
#226Synthesis of imidazole 2-thiones thiohydantoins
#227Method of making imidazole-2-ones and 2-thiones
#2282-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
#229Cyclohexyl sulfonamide derivatives
#2303-phenylpropionic acid derivatives
#231Potassium channel modulators
#232Ketone compounds and compositions for cholesterol management and related uses
#233Ketone compounds and compositions for cholesterol management and related uses
#234Resorcinol derivatives
#235Imidazole compounds that modulate HSP90 activity
#2364-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#237Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
#238Nonsedating α-2 agonists
#239Alpha-2 adrenergic agonists
#240Novel pyrroles and imidazoles
#241Aryl and heteroaryl compounds and methods to modulate coagulation
#242Non-imidazole aryloxyalkylamines
#243Inhibitors of cdc25 phosphatases
#244Substituted alcohols useful in treatment of Alzheimer's disease
#245Beta-agonists, processes for preparing them and their use as pharmaceutical compositions
#246Tetralin and indane derivatives and uses thereof
#247Compounds for the treatment of CNS and amyloid associated diseases
#248Imidazole and benzimidazole derivatives useful as histamine Hantagonists
#2493-phenylpropionic acid derivatives
#250Inhibitors of Cdc25 phosphatases
#251Hemiasterlin derivatives and uses thereof
#2524-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
#2532-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
#254Non-nucleoside reverse transcriptase inhibitors
#255Aminoalkylphosphonates and related compounds as Edg receptor agonists
#256Piperazine derivative
#2574-(Condensed cyclicmethyl)-imidazole-2-thiones acting as αadrenergic agonists
#258Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
#259Tricyclic steroid hormone nuclear receptor modulators
#260Mercaptoimidazoles as CCR2 receptor antagonists
#261Process for preparing substituted imidazole derivatives and intermediates used in the process
#26211-Beta HSD1 inhibitors
#263Cannabinoid receptor ligands
#264Substituted heterocycles for the treatment of diabetes and other diseases
#265Non nucleoside reverse transcriptase inhibitors
#266Resorcinol derivatives
#267Novel piperidine and piperazine derivatives
#2684-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#269Scalable synthesis of imidazole derivatives
#270Novel imidazoles
#271β-amyloid protein production/secretion inhibitor
#272Non-imidazole aryloxypiperidines
#273Chain oligolactic acid thioester
#274Ion channel modulators
#275N-acylsulfonamide apoptosis promoters
#276Substituted cyclic compounds
#277Aminoalkylphosphonates and related compounds as edg receptor agonists
#278Nematicidal trifluorobutenyl imidazole thioether derivatives
#2794-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
#280Imidazolidinedione derivatives for the treatment of diabetes and other diseases
#281Substituted cyclic compounds
#282Nonsedating α-2 agonists
#283Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
#284Non-nucleoside reverse transcriptase inhibitors
#285Cyanoalkylamino derivatives as protease inhibitors
#286Potassium channel modulators
#287Acyl sulfonamides as inhibitors of HIV integrase